Тендеры России
Поиск
Dinutuximab (Genetical Recombination) (17.5 mg/5 mL/1 vial) 24 vials (Япония - Тендер #41143062) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Япония (другие тендеры и закупки Япония) Организатор тендера: Government Procurement Japan Номер конкурса: 41143062 Дата публикации: 26-04-2023 Источник тендера: Государственные закупки Японии |
||
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
| Publishing date | Apr 26, 2023 |
|---|---|
| Type of notice | Notice of Procurement (Goods & Services) |
| Procurement entity | National University Corporation - Hokkaido |
| Classification | 0004 Medical & Pharmaceutical Products |
| Summay of notice |
⑴ Official in charge of disbursement of the procuring entity : Yuji Nishikawa, President, Asahikawa Medical University ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : Dinutuximab (Genetical Recombination) (17.5 mg/5 mL/1 vial) 24 vials ⑷ Delivery period : From 1, July, 2023 through 31, March, 2024 ⑸ Delivery place : Asahikawa Medical University Hospital ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article 4 and 5 of the Regulation concerning the Contract for Asahikawa Medical University Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause, B have the Grade A, Grade B or Grade C qualification during fiscal 2023 in the Hokkaido area in Sales of products for participating in tenders by Single qualification for every ministry and agency, C prove to have obtained the first-class license for selling drugs in accordance with The Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D not be currently under a suspension of business order as instructed by the President, The National University Corporation Asahikawa Medical University. ⑺ Time limit of tender : 17 : 00 16, June, 2023 ⑻ Contact point for the notice : Takashi Sunada, Procurement Section, Accounting Division, Asahikawa Medical University, 2-1-1-1 Midorigaokahigashi Asahikawa-shi Hokkaido 078-8510 Japan, TEL 0166-69-3071 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents. |